Is there a place for engineered immune cell therapies in autoimmune diseases?

Luca Perico; Federica Casiraghi; Ariela Benigni; Giuseppe Remuzzi

doi:10.1016/j.molmed.2025.01.011

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2010

New therapies for asthma: is there any progress?

Peter J Barnes

Article2019

Metabolic and Non-Metabolic Peripheral Neuropathy: Is there a Place for Therapeutic Apheresis?

Richard Straube, Gregor Müller, Karin Voit-Bak, Sergey Tselmin, Ulrich Julius, Ulrike Schatz, Hannes Rietzsch, Heinz Reichmann, George Chrousos, Annette Schürmann, Luka Jarc, Tjalf Ziemssen, Timo Siepmann, Stefan R. Bornstein

Preprint2023

A novel targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases

Luca Perico, Federica Casiraghi, Fabiane Sônego, Marta Todeschini, Daniela Corna, Domenico Cerullo, Anna Pezzotta, Patricia Isnard‐Petit, Silvia Faravelli, Federico Forneris, Kader Thiam, Giuseppe Remuzzi, Ariela Benigni

Article1992

[Mechanisms of immune homeostasis: implications for the pathogenesis of autoimmune diseases].

Guido Guido Kroemer

Article2015

Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? No

Cecilia Becattini, Giancarlo Agnelli